Aresgado, Concordia .

HRN: 27-62-62  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/23/2025
08/30/2025
IV
2.25g
Q6
CAPmr
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines